← Back
$MLTX All transactions

MoonLake Immunotherapeutics

▲ BUY
6 / 10

Conviction

$ Value

$99K

Shares

10,870

Price

$9

Filed

Oct 9

Why this score? (6/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Bodenstedt Matthias

Title

Chief Financial Officer

CIK

0001920545

Roles

Officer

Transaction Details

Transaction Date

2025-10-08

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

627,536

Footnotes

The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $9.085 to $9.091244. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.

Filing Info

Accession No.

0001213900-25-097594

Form Type

4

Issuer CIK

0001821586

Bodenstedt Matthias's History

Date Ticker Type Value
2026-04-14 MLTX $47K
2026-04-10 MLTX $38K
2026-04-09 MLTX $1.6M
2026-01-07 MLTX A $0
2025-12-19 MLTX C
2025-12-19 MLTX D
2025-12-19 MLTX C
2025-10-08 MLTX $99K

Other Insiders at MLTX (90d)

Insider Bought Sold Last
BVF PARTNERS L P/IL $63.0M 2026-03-31
Santos da Silva Jorge
Chief Executive Officer
$2.8M 2026-04-13
Bodenstedt Matthias
Chief Financial Officer
$1.7M 2026-04-14